Literature DB >> 9801331

Serologic evidence of a natural infection of white-tailed deer with the agent of human granulocytic ehrlichiosis in Wisconsin and Maryland.

J J Walls1, K M Asanovich, J S Bakken, J S Dumler.   

Abstract

White-tailed deer participate in the maintenance of the Ixodes tick life cycle and are reservoirs for some tick-borne infectious agents. Deer may be useful sentinels for tick-transmitted agents, such as ehrlichiae. In order to determine whether white-tailed deer are markers of natural transmission or are reservoirs for the human granulocytic ehrlichiosis (HGE) agent, we performed indirect immunofluorescent-antibody (IFA) tests and immunoblotting with the HGE agent and Ehrlichia chaffeensis on sera from 43 and 294 deer captured in northwest Wisconsin during 1994 and 1995, respectively, and 12 deer from southern Maryland. According to IFA testing, 47% of 1994 Wisconsin sera, 60% of 1995 Wisconsin sera, and 25% of Maryland sera contained HGE agent antibodies. All IFA-positive deer sera tested reacted with the 44-kDa band which is unique to the Ehrlichia phagocytophila group. Serologic reactions to E. chaffeensis were detected by IFA testing in 15 of 337 (4%) Wisconsin deer and in 10 of 12 (83%) Maryland deer, while 60 and 80% of E. chaffeensis IFA-positive Wisconsin and Maryland deer sera, respectively, reacted with the E. chaffeensis 28- to 29-kDa antigens by immunoblotting. A total of 4% of deer from Wisconsin and 25% of deer from Maryland were found by IFA testing to have antibodies to both the HGE agent and E. chaffeensis; 75% of these were confirmed to contain E. chaffeensis antibodies by immunoblotting. These results suggest that white-tailed deer in diverse geographical regions of the United States are naturally infected with the HGE agent, E. chaffeensis, or both and that these animals, and potentially humans, are exposed to infected ticks at a high frequency in nature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801331      PMCID: PMC96198          DOI: 10.1128/CDLI.5.6.762-765.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Ehrlichia-like 16S rDNA sequence from wild white-tailed deer (Odocoileus virginianus).

Authors:  J E Dawson; C K Warner; V Baker; S A Ewing; D E Stallknecht; W R Davidson; A A Kocan; J M Lockhart; J G Olson
Journal:  J Parasitol       Date:  1996-02       Impact factor: 1.276

2.  Human granulocytic ehrlichiosis in Massachusetts.

Authors:  S R Telford; T J Lepore; P Snow; C K Warner; J E Dawson
Journal:  Ann Intern Med       Date:  1995-08-15       Impact factor: 25.391

Review 3.  Environmental risk and prevention of Lyme disease.

Authors:  D Fish
Journal:  Am J Med       Date:  1995-04-24       Impact factor: 4.965

4.  Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California.

Authors:  K M Asanovich; J S Bakken; J E Madigan; M Aguero-Rosenfeld; G P Wormser; J S Dumler
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

5.  Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.

Authors:  J S Dumler; K M Asanovich; J S Bakken; P Richter; R Kimsey; J E Madigan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

7.  Mice as reservoirs of the Lyme disease spirochete.

Authors:  J F Levine; M L Wilson; A Spielman
Journal:  Am J Trop Med Hyg       Date:  1985-03       Impact factor: 2.345

8.  Direct cultivation of the causative agent of human granulocytic ehrlichiosis.

Authors:  J L Goodman; C Nelson; B Vitale; J E Madigan; J S Dumler; T J Kurtti; U G Munderloh
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

9.  Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

Authors:  J S Bakken; J Krueth; C Wilson-Nordskog; R L Tilden; K Asanovich; J S Dumler
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

10.  Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

Authors:  P Pancholi; C P Kolbert; P D Mitchell; K D Reed; J S Dumler; J S Bakken; S R Telford; D H Persing
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  12 in total

1.  Anaplasma phagocytophilum in central and western Wisconsin: a molecular survey.

Authors:  M Michalski; C Rosenfield; M Erickson; R Selle; K Bates; D Essar; R Massung
Journal:  Parasitol Res       Date:  2006-11       Impact factor: 2.289

2.  Anaplasma odocoilei sp. nov. (family Anaplasmataceae) from white-tailed deer (Odocoileus virginianus).

Authors:  Cynthia M Tate; Elizabeth W Howerth; Daniel G Mead; Vivien G Dugan; M Page Luttrell; Alexandra I Sahora; Ulrike G Munderloh; William R Davidson; Michael J Yabsley
Journal:  Ticks Tick Borne Dis       Date:  2012-12-29       Impact factor: 3.744

3.  Molecular characterization of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes scapularis ticks from Pennsylvania.

Authors:  Joshua W Courtney; Richard L Dryden; Jill Montgomery; Bradley S Schneider; Gary Smith; Robert F Massung
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  PCR detection and serological evidence of granulocytic ehrlichial infection in roe deer (Capreolus capreolus) and chamois (Rupicapra rupicapra).

Authors:  Jorge S Liz; John W Sumner; Kurt Pfister; Michel Brossard
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Authors:  Cynthia M Tate; Daniel G Mead; M Page Luttrell; Elizabeth W Howerth; Vivien G Dugan; Ulrike G Munderloh; William R Davidson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Characterization of Anaplasma phagocytophilum major surface protein 5 and the extent of its cross-reactivity with A. marginale.

Authors:  N I Strik; A R Alleman; A F Barbet; H L Sorenson; H L Wamsley; F P Gaschen; N Luckschander; S Wong; F Chu; J E Foley; A Bjoersdorff; S Stuen; D P Knowles
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

7.  Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut.

Authors:  K C Stafford; R F Massung; L A Magnarelli; J W Ijdo; J F Anderson
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

8.  Genetic variability and stability of Anaplasma phagocytophila msp2 (p44).

Authors:  Karen Caspersen; Jin-Ho Park; Surekha Patil; J Stephen Dumler
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

9.  PCR detection of granulocytic ehrlichiae in Ixodes ricinus ticks and wild small mammals in western Switzerland.

Authors:  J S Liz; L Anderes; J W Sumner; R F Massung; L Gern; B Rutti; M Brossard
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Analysis of genetic identity of North American Anaplasma phagocytophilum strains by pulsed-field gel electrophoresis.

Authors:  J S Dumler; K M Asanovich; J S Bakken
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.